Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Hyaluronan synthase 3 mediated oncogenic action through forming inter-regulation loop with tumor necrosis factor alpha in oral cancer.

Kuo YZ, Fang WY, Huang CC, Tsai ST, Wang YC, Yang CL, Wu LW.

Oncotarget. 2017 Feb 28;8(9):15563-15583. doi: 10.18632/oncotarget.14697.

2.

Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight.

Sato N, Kohi S, Hirata K, Goggins M.

Cancer Sci. 2016 May;107(5):569-75. doi: 10.1111/cas.12913. Epub 2016 Mar 18. Review.

3.

PP2B and ERK1/2 regulate hyaluronan synthesis of HT168 and WM35 human melanoma cell lines.

Katona É, Juhász T, Somogyi CS, Hajdú T, Szász C, Rácz K, Kókai E, Gergely P, Zákány R.

Int J Oncol. 2016 Mar;48(3):983-97. doi: 10.3892/ijo.2015.3313. Epub 2015 Dec 28.

4.

Esophageal Squamous Cell Carcinoma Cells Modulate Chemokine Expression and Hyaluronan Synthesis in Fibroblasts.

Kretschmer I, Freudenberger T, Twarock S, Yamaguchi Y, Grandoch M, Fischer JW.

J Biol Chem. 2016 Feb 19;291(8):4091-106. doi: 10.1074/jbc.M115.708909. Epub 2015 Dec 23.

5.

Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells.

Chanmee T, Ontong P, Kimata K, Itano N.

Front Oncol. 2015 Aug 10;5:180. doi: 10.3389/fonc.2015.00180. eCollection 2015. Review.

6.

Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer.

Misra S, Hascall VC, Markwald RR, Ghatak S.

Front Immunol. 2015 May 6;6:201. doi: 10.3389/fimmu.2015.00201. eCollection 2015. Review.

7.

Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer.

Cho EJ, Sun B, Doh KO, Wilson EM, Torregrosa-Allen S, Elzey BD, Yeo Y.

Biomaterials. 2015 Jan;37:312-9. doi: 10.1016/j.biomaterials.2014.10.039. Epub 2014 Oct 24.

8.

A role for versican in the development of leiomyosarcoma.

Keire PA, Bressler SL, Lemire JM, Edris B, Rubin BP, Rahmani M, McManus BM, van de Rijn M, Wight TN.

J Biol Chem. 2014 Dec 5;289(49):34089-103. doi: 10.1074/jbc.M114.607168. Epub 2014 Oct 15.

9.

Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment.

Kultti A, Zhao C, Singha NC, Zimmerman S, Osgood RJ, Symons R, Jiang P, Li X, Thompson CB, Infante JR, Jacobetz MA, Tuveson DA, Frost GI, Shepard HM, Huang Z.

Biomed Res Int. 2014;2014:817613. doi: 10.1155/2014/817613. Epub 2014 Jul 24.

10.

Low molecular weight hyaluronan induces lymphangiogenesis through LYVE-1-mediated signaling pathways.

Wu M, Du Y, Liu Y, He Y, Yang C, Wang W, Gao F.

PLoS One. 2014 Mar 25;9(3):e92857. doi: 10.1371/journal.pone.0092857. eCollection 2014.

11.

Physical biology in cancer. 3. The role of cell glycocalyx in vascular transport of circulating tumor cells.

Mitchell MJ, King MR.

Am J Physiol Cell Physiol. 2014 Jan 15;306(2):C89-97. doi: 10.1152/ajpcell.00285.2013. Epub 2013 Oct 16. Review.

12.

Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma.

Siiskonen H, Poukka M, Tyynelä-Korhonen K, Sironen R, Pasonen-Seppänen S.

BMC Cancer. 2013 Apr 5;13:181. doi: 10.1186/1471-2407-13-181.

13.

Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.

Choi KY, Saravanakumar G, Park JH, Park K.

Colloids Surf B Biointerfaces. 2012 Nov 1;99:82-94. doi: 10.1016/j.colsurfb.2011.10.029. Epub 2011 Oct 20. Review.

14.

Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.

Twarock S, Freudenberger T, Poscher E, Dai G, Jannasch K, Dullin C, Alves F, Prenzel K, Knoefel WT, Stoecklein NH, Savani RC, Homey B, Fischer JW.

Mol Cancer. 2011 Mar 23;10:30. doi: 10.1186/1476-4598-10-30.

15.

Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Misra S, Heldin P, Hascall VC, Karamanos NK, Skandalis SS, Markwald RR, Ghatak S.

FEBS J. 2011 May;278(9):1429-43. doi: 10.1111/j.1742-4658.2011.08071.x. Epub 2011 Mar 25. Review.

16.

Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression.

Sprenger CC, Plymate SR, Reed MJ.

Int J Cancer. 2010 Dec 15;127(12):2739-48. doi: 10.1002/ijc.25615. Epub 2010 Oct 8. Review.

17.

Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma.

Nykopp TK, Rilla K, Tammi MI, Tammi RH, Sironen R, Hämäläinen K, Kosma VM, Heinonen S, Anttila M.

BMC Cancer. 2010 Sep 27;10:512. doi: 10.1186/1471-2407-10-512.

18.

Hyaluronan inhibits postchemotherapy tumor regrowth in a colon carcinoma xenograft model.

Mueller BM, Schraufstatter IU, Goncharova V, Povaliy T, DiScipio R, Khaldoyanidi SK.

Mol Cancer Ther. 2010 Nov;9(11):3024-32. doi: 10.1158/1535-7163.MCT-10-0529. Epub 2010 Sep 10.

19.

Cytokines and growth factors stimulate hyaluronan production: role of hyaluronan in epithelial to mesenchymal-like transition in non-small cell lung cancer.

Chow G, Tauler J, Mulshine JL.

J Biomed Biotechnol. 2010;2010:485468. doi: 10.1155/2010/485468. Epub 2010 Jun 30.

20.

Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.

Twarock S, Tammi MI, Savani RC, Fischer JW.

J Biol Chem. 2010 Jul 23;285(30):23276-84. doi: 10.1074/jbc.M109.093146. Epub 2010 May 12.

Supplemental Content

Support Center